Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.

导出 OA

翻译打印收藏纠错

第一作者： Kevin R,Betts

第一单位： U.S. Food and Drug Administration, Office of Prescription Drug Promotion, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA. Electronic address: kevin.betts@fda.hhs.gov.

作者： Kevin R,Betts ^[1] ; Vanessa,Boudewyns ^[2] ; Kathryn J,Aikin ^[3] ; Claudia,Squire ^[4] ; Suzanne,Dolina ^[5] ; Jennifer J,Hayes ^[6] ; Brian G,Southwell ^[7]

作者单位： U.S. Food and Drug Administration, Office of Prescription Drug Promotion, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA. Electronic address: kevin.betts@fda.hhs.gov. ^[1] RTI International, Center for Communication Science, 3040 E. Cornwallis Rd., Research Triangle Park, NC 27709, USA. Electronic address: vboudewyns@rti.org. ^[2] U.S. Food and Drug Administration, Office of Prescription Drug Promotion, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA. Electronic address: kathryn.aikin@fda.hhs.gov. ^[3] RTI International, Center for Communication Science, 3040 E. Cornwallis Rd., Research Triangle Park, NC 27709, USA. Electronic address: cms@rti.org. ^[4] RTI International, Center for Communication Science, 3040 E. Cornwallis Rd., Research Triangle Park, NC 27709, USA. Electronic address: sdolina@rti.org. ^[5] RTI International, Center for Communication Science, 3040 E. Cornwallis Rd., Research Triangle Park, NC 27709, USA. Electronic address: jhayes@rti.org. ^[6] RTI International, Center for Communication Science, 3040 E. Cornwallis Rd., Research Triangle Park, NC 27709, USA. Electronic address: bsouthwell@rti.org. ^[7]

关键词 Direct-to-consumer prescription drug advertising Disclosures Food and drug administration Major statement Prescription drugs Risk communication